C-MER Medical Holdings Limited (03309) reported the repurchase of 0.20 million ordinary shares on 24 February 2026 at prices ranging from HKD 1.54 to HKD 1.57, with a volume-weighted average price of approximately HKD 1.56. The total payment for this transaction was HKD 311,200.

After the repurchase, the company holds 20.62 million shares as treasury shares, increased from 20.42 million. The number of issued shares excluding treasury shares is 1.21 billion, while total issued shares remain at 1.23 billion.

According to the repurchase mandate dated 19 May 2025, C-MER Medical Holdings Limited is authorized to repurchase up to 125.56 million shares. A total of 0.20 million shares have been repurchased so far under this mandate, representing approximately 0.0159% of the total issued shares (excluding treasury shares) as of the date of the mandate.